MHRA Approves Krazati: A Breakthrough Therapy for Advanced Non-Small Cell Lung Cancer
Green light from MHRA for Krazati (Adagrasib) – that targets NSCLC....
Green light from MHRA for Krazati (Adagrasib) – that targets NSCLC....
Mobile stroke units (MSUs) have emerged as a game-changer in prehospital stroke...
Intermittent fasting (IF) has emerged as a promising dietary strategy, offering...
A new study found that each additional metabolic comorbidity in T2D patients...
Recent findings suggest that the presence of ctDNA predicts poorer disease-free...
AstraZeneca's new drug – Sipavibart, represents a significant step forward in...
ICMRA's 10th anniversary conference and Plenary in Melbourne aimed to bring...
As reports of turmeric-induced liver injury surface, a deeper understanding of...
Restoring extinct species stands at the forefront of scientific innovation, and...